Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/1/16 → 01/25/19 |
Funding
- Otsuka Pharmaceutical Development and Commercialization Inc: $8,050.00
A Phase 3b; Multicenter, Open-Label, Randomized Withdrawal Trial of the Effects of Titrated Oral SAMSCA (Tolvaptan) on Serum Sodium, Pharmacokinetics, and Safety in Children and Adolescent Subjects Hospitalized with Euvolemic or Hypervolemi
- Woroniecki, Robert (PI)
- Supe-Markovina, Katarina (CoPI)
Project: Research